Methods In Haem 2 + Leukemias 2 & 3 Flashcards

1
Q

Describe technologies commonly used in hematological diagnosis and application to particular disease states(example).

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Compare Synchronised VS Un-Synchronised technique.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Brief notes on staining.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Explain the mechanism of FISH.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the diagnosis/clinical managements of CML, AML, CLL, and MCL.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Brief notes on PCR and Rq-PCR.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Define flow cytometry and mechanisms behind it.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the five come pats of flow cyt?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Outline gating and immuniphenotyping …

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the advantages and disadvantages of each technique in diagnosis?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Why is cytogenetics and MRD analysis by RQ-PCR used in tandem for follow up?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Understand the pathogenesis and prognosis of Acute Myeloid Leukemia (AML). Explain AML.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are some prognostic indicates of AML? What its incidence in populations?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Outline and compare AML classifications from WHO and FAB.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Explain the core binding factor (CBF) and its relevant mechanism.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Explain the CBF mechanism in Patients with AML stage M2: t(8;21) RUNX1

A
17
Q

Explain the CBF mechanism Patients with AML stage M4: t(6;16) or inversion

A
18
Q

Outline the therapies used in AML patients (except M3) + prognosis.

A
19
Q

Explain the relevance of retinoic acid.

A